Genome sequencing company G&DX surpassing a hundred million dollars in revenue for the first time in its most recent quarter. A lot more than that though. They also talked about how they're raising their guidance for the fiscal year.They flipped to a profit from a loss in the previous quarter and saw some pretty impressive growth particularly when it came to exo and genome testing sales which were up by 69%. The company screens for and diagnoses rare diseases in newborns. And joining us right now is Katheri ...